BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Andrews EB, Eaton SC, Hollis KA, Hopkins JS, Ameen V, Hamm LR, Cook SF, Tennis P, Mangel AW. Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey. Aliment Pharmacol Ther 2005;22:935-42. [DOI: 10.1111/j.1365-2036.2005.02671.x] [Cited by in Crossref: 110] [Cited by in F6Publishing: 109] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Goodoory VC, Ng CE, Black CJ, Ford AC. Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom. Aliment Pharmacol Ther 2022;56:110-20. [PMID: 35491477 DOI: 10.1111/apt.16939] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
2 Fitzpatrick JA, Melton SL, Yao CK, Gibson PR, Halmos EP. Dietary management of adults with IBD - the emerging role of dietary therapy. Nat Rev Gastroenterol Hepatol 2022. [PMID: 35577903 DOI: 10.1038/s41575-022-00619-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
3 Yao C, Li Y, Luo L, Xie F, Xiong Q, Li T, Yang C, Feng PM. Significant Differences in Gut Microbiota Between Irritable Bowel Syndrome with Diarrhea and Healthy Controls in Southwest China. Dig Dis Sci 2022. [PMID: 35503487 DOI: 10.1007/s10620-022-07500-0] [Reference Citation Analysis]
4 Layer P, Andresen V, Allescher H, Bischoff SC, Claßen M, Elsenbruch S, Freitag M, Frieling T, Gebhard M, Goebel-Stengel M, Häuser W, Holtmann G, Keller J, Kreis ME, Kruis W, Langhorst J, Jansen PL, Madisch A, Mönnikes H, Müller-Lissner S, Niesler B, Pehl C, Pohl D, Raithel M, Röhrig-Herzog G, Schemann M, Schmiedel S, Schwille-Kiuntke J, Storr M, Preiß JC, Andus T, Buderus S, Ehlert U, Engel M, Enninger A, Fischbach W, Gillessen A, Gschossmann J, Gundling F, Haag S, Helwig U, Hollerbach S, Karaus M, Katschinski M, Krammer H, Kuhlbusch-Zicklam R, Matthes H, Menge D, Miehlke S, Posovszky MC, Schaefert R, Schmidt-Choudhury A, Schwandner O, Schweinlin A, Seidl H, Stengel A, Tesarz J, van der Voort I, Voderholzer W, von Boyen G, von Schönfeld J, Wedel T; Collaborators:., in Zusammenarbeit mit:., Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin (DEGAM)., Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)., Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV)., Deutsche Gesellschaft für Ernährungsmedizin (DGEM)., Deutsche Gesellschaft für Geriatrie (DGG)., Deutsche Gesellschaft für Innere Medizin (DGIM)., Deutsche Gesellschaft für Naturheilkunde (DGNHK)., Deutsche Gesellschaft für Pathologie und Bundesverband deutscher Pathologen e. V. (DGP/BDP)., Deutsche Gesellschaft für Psychosomatische Medizin und Ärztliche Psychotherapie (DGPM)., Deutsche Gesellschaft für Verhaltensmedizin und Verhaltensmodifikation (DGVM)., Deutsche Schmerzgesellschaft e. V., Deutsches Kollegium für Psychosomatische Medizin (DKPM), Deutsche Gesellschaft für Tropenmedizin und Internationale Gesundheit (DTG)., Gesellschaft für Pädiatrische Gastroenterologie und Ernährung (GPGE)., Deutschen Gesellschaft für Kinder- und Jugendmedizin (DGKJ)., Swiss Society of Neurogastroenterology and Motility (SwissNGM)., Informationsforum für Patient:innen mit Magen-Darm-Erkrankungen (MAGDA). Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) – Juni 2021 – AWMF-Registriernummer: 021/016. Z Gastroenterol 2021;59:1323-415. [PMID: 34891206 DOI: 10.1055/a-1591-4794] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Lazebnik LB, Golovanova EV, Volel BA, Korochanskaya NV, Lyalyukova EA, Mokshina MV, Mekhtiev SN, Mekhtieva OA, Metsaeva ZV, Petelin DS, Simanenkov VI, Sitkin SI, Cheremushkin SV, Chernogorova MV, Khavkin АI. Functional gastrointestinal disorders. Overlap syndrome Clinical guidelines of the Russian Scientific Medical Society of Internal Medicine and Gastroenterological Scientific Society of Russia. jour 2021. [DOI: 10.31146/1682-8658-ecg-192-8-5-117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Black CJ, Yiannakou Y, Guthrie EA, West R, Houghton LA, Ford AC. A Novel Method to Classify and Subgroup Patients With IBS Based on Gastrointestinal Symptoms and Psychological Profiles. Am J Gastroenterol 2021;116:372-81. [PMID: 33110014 DOI: 10.14309/ajg.0000000000000975] [Cited by in Crossref: 7] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
7 Bouchoucha M, Deutsch D, Uong P, Mary F, Sabate JM, Benamouzig R. Characteristics of patients with overlap functional gastrointestinal disorders. J Gastroenterol Hepatol 2021;36:2171-9. [PMID: 33555092 DOI: 10.1111/jgh.15438] [Reference Citation Analysis]
8 Krouwel M, Farley A, Greenfield S, Ismail T, Jolly K. Systematic review, meta-analysis with subgroup analysis of hypnotherapy for irritable bowel syndrome, effect of intervention characteristics. Complement Ther Med 2021;57:102672. [PMID: 33508441 DOI: 10.1016/j.ctim.2021.102672] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Grover M, Kolla BP, Pamarthy R, Mansukhani MP, Breen-Lyles M, He JP, Merikangas KR. Psychological, physical, and sleep comorbidities and functional impairment in irritable bowel syndrome: Results from a national survey of U.S. adults. PLoS One 2021;16:e0245323. [PMID: 33444383 DOI: 10.1371/journal.pone.0245323] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
10 Fatahi S, Matin SS, Sohouli MH, Găman MA, Raee P, Olang B, Kathirgamathamby V, Santos HO, Guimarães NS, Shidfar F. Association of dietary fiber and depression symptom: A systematic review and meta-analysis of observational studies. Complement Ther Med 2021;56:102621. [PMID: 33220451 DOI: 10.1016/j.ctim.2020.102621] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
11 Rotaru TȘ, Frățilă OC, Bărboi O, Ciortescu I, Mihai C, Anton C, Ștefănescu G, Drug V. A comparison using standardized measures for patients with irritable bowel syndrome: Trust in the gastroenterologist and reliance on the internet. Neurogastroenterol Motil 2021;33:e13977. [PMID: 32875697 DOI: 10.1111/nmo.13977] [Reference Citation Analysis]
12 Patel RS, Goyal H, Satodiya R, Tankersley WE. Relationship of Cannabis Use Disorder and Irritable Bowel Syndrome (IBS): An Analysis of 6.8 Million Hospitalizations in the United States. Substance Use & Misuse 2020;55:281-90. [DOI: 10.1080/10826084.2019.1664591] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
13 Spillebout A, Dechelotte P, Ladner J, Tavolacci M. Mental health among university students with eating disorders and irritable bowel syndrome in France. Revue d'Épidémiologie et de Santé Publique 2019;67:295-301. [DOI: 10.1016/j.respe.2019.04.056] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
14 Dale HF, Jensen C, Hausken T, Valeur J, Hoff DAL, Lied GA. Effects of a Cod Protein Hydrolysate Supplement on Symptoms, Gut Integrity Markers and Fecal Fermentation in Patients with Irritable Bowel Syndrome. Nutrients 2019;11:E1635. [PMID: 31319590 DOI: 10.3390/nu11071635] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
15 Ashktorab H, Soleimani A, Singh G, Amin A, Tabtabaei S, Latella G, Stein U, Akhondzadeh S, Solanki N, Gondré-Lewis MC, Habtezion A, Brim H. Saffron: The Golden Spice with Therapeutic Properties on Digestive Diseases. Nutrients 2019;11:E943. [PMID: 31027364 DOI: 10.3390/nu11050943] [Cited by in Crossref: 39] [Cited by in F6Publishing: 64] [Article Influence: 13.0] [Reference Citation Analysis]
16 Schauer B, Grabe HJ, Ittermann T, Lerch MM, Weiss FU, Mönnikes H, Völzke H, Enck P, Schwille-Kiuntke J. Irritable bowel syndrome, mental health, and quality of life: Data from a population-based survey in Germany (SHIP-Trend-0). Neurogastroenterol Motil 2019;31:e13511. [PMID: 30444067 DOI: 10.1111/nmo.13511] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
17 Barish CF, Crozier RA, Griffin PH. Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation. Curr Med Res Opin 2019;35:81-5. [PMID: 30277094 DOI: 10.1080/03007995.2018.1527303] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
18 Krouwel M, Greenfield S, Farley A, Ismail T, Jolly K. Factors which affect the efficacy of hypnotherapy for IBS: Protocol for a systematic review and meta-regression. European Journal of Integrative Medicine 2018;21:58-62. [DOI: 10.1016/j.eujim.2018.06.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Testa A, Imperatore N, Rispo A, Rea M, Tortora R, Nardone OM, Lucci L, Accarino G, Caporaso N, Castiglione F. Beyond Irritable Bowel Syndrome: The Efficacy of the Low Fodmap Diet for Improving Symptoms in Inflammatory Bowel Diseases and Celiac Disease. Dig Dis. 2018;36:271-280. [PMID: 29763907 DOI: 10.1159/000489487] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
20 Singh P, Mitsuhashi S, Ballou S, Rangan V, Sommers T, Cheng V, Iturrino-Moreda J, Friedlander D, Nee J, Lembo A. Demographic and Dietary Associations of Chronic Diarrhea in a Representative Sample of Adults in the United States. Am J Gastroenterol 2018;113:593-600. [PMID: 29610515 DOI: 10.1038/ajg.2018.24] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
21 Giannetti E, Maglione M, Alessandrella A, Strisciuglio C, De Giovanni D, Campanozzi A, Miele E, Staiano A. A Mixture of 3 Bifidobacteria Decreases Abdominal Pain and Improves the Quality of Life in Children With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Trial. J Clin Gastroenterol 2017;51:e5-e10. [PMID: 27306945 DOI: 10.1097/MCG.0000000000000528] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 8.8] [Reference Citation Analysis]
22 Schäfer SK, Weidner KJ, Hoppner J, Becker N, Friedrich D, Stokes CS, Lammert F, Köllner V. Design and validation of a German version of the GSRS-IBS - an analysis of its psychometric quality and factorial structure. BMC Gastroenterol 2017;17:139. [PMID: 29202711 DOI: 10.1186/s12876-017-0684-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
23 Chatila R, Merhi M, Hariri E, Sabbah N, Deeb ME. Irritable bowel syndrome: prevalence, risk factors in an adult Lebanese population. BMC Gastroenterol 2017;17:137. [PMID: 29197339 DOI: 10.1186/s12876-017-0698-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
24 Azuma K, Uchiyama I. Association between environmental noise and subjective symptoms related to cardiovascular diseases among elderly individuals in Japan. PLoS One 2017;12:e0188236. [PMID: 29145457 DOI: 10.1371/journal.pone.0188236] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
25 Altobelli E, Del Negro V, Angeletti PM, Latella G. Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis. Nutrients. 2017;9. [PMID: 28846594 DOI: 10.3390/nu9090940] [Cited by in Crossref: 113] [Cited by in F6Publishing: 83] [Article Influence: 22.6] [Reference Citation Analysis]
26 Tack J, Schumacher K, Tonini G, Scartoni S, Capriati A, Maggi CA; Iris-2 investigators. The neurokinin-2 receptor antagonist ibodutant improves overall symptoms, abdominal pain and stool pattern in female patients in a phase II study of diarrhoea-predominant IBS. Gut 2017;66:1403-13. [PMID: 27196574 DOI: 10.1136/gutjnl-2015-310683] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
27 Iacovou M, Mulcahy EC, Truby H, Barrett JS, Gibson PR, Muir JG. Reducing the maternal dietary intake of indigestible and slowly absorbed short-chain carbohydrates is associated with improved infantile colic: a proof-of-concept study. J Hum Nutr Diet 2018;31:256-65. [PMID: 28631347 DOI: 10.1111/jhn.12488] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
28 Mansouri A, Rarani MA, Fallahi M, Alvandi I. Irritable bowel syndrome is concentrated in people with higher educations in Iran: an inequality analysis. Epidemiol Health 2017;39:e2017005. [PMID: 28171714 DOI: 10.4178/epih.e2017005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
29 Zhang F, Xiang W, Li CY, Li SC. Economic burden of irritable bowel syndrome in China. World J Gastroenterol 2016; 22(47): 10450-10460 [PMID: 28058026 DOI: 10.3748/wjg.v22.i47.10450] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
30 Lee SK, Yoon DW, Lee S, Kim J, Choi KM, Shin C. The association between irritable bowel syndrome and the coexistence of depression and insomnia. J Psychosom Res 2017;93:1-5. [PMID: 28107884 DOI: 10.1016/j.jpsychores.2016.12.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
31 Marsh A, Eslick EM, Eslick GD. Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur J Nutr 2016;55:897-906. [DOI: 10.1007/s00394-015-0922-1] [Cited by in Crossref: 179] [Cited by in F6Publishing: 178] [Article Influence: 25.6] [Reference Citation Analysis]
32 Nagata N, Sakamoto K, Arai T, Niikura R, Shimbo T, Shinozaki M, Ihana N, Sekine K, Okubo H, Watanabe K, Sakurai T, Yokoi C, Yanase M, Akiyama J, Uemura N, Noda M. Effect of body mass index and intra-abdominal fat measured by computed tomography on the risk of bowel symptoms. PLoS One 2015;10:e0123993. [PMID: 25906052 DOI: 10.1371/journal.pone.0123993] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
33 Zhu L, Huang D, Shi L, Liang L, Xu T, Chang M, Chen W, Wu D, Zhang F, Fang X. Intestinal symptoms and psychological factors jointly affect quality of life of patients with irritable bowel syndrome with diarrhea. Health Qual Life Outcomes. 2015;13:49. [PMID: 25925746 DOI: 10.1186/s12955-015-0243-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
34 Good L, Rosario R, Panas R. New therapeutic option for irritable bowel syndrome: Serum-derived bovine immunoglobulin. World J Gastroenterol 2015; 21(11): 3361-3366 [PMID: 25805945 DOI: 10.3748/wjg.v21.i11.3361] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
35 Iorio N, Makipour K, Palit A, Friedenberg FK. Post-traumatic Stress Disorder Is Associated With Irritable Bowel Syndrome in African Americans. J Neurogastroenterol Motil 2014;20:523-30. [PMID: 25273122 DOI: 10.5056/jnm14040] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
36 Lin S, Mooney PD, Kurien M, Aziz I, Leeds JS, Sanders DS. Prevalence, investigational pathways and diagnostic outcomes in differing irritable bowel syndrome subtypes. European Journal of Gastroenterology & Hepatology 2014;26:1176-80. [DOI: 10.1097/meg.0000000000000171] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
37 Azuma K, Uchiyama I, Katoh T, Ogata H, Arashidani K, Kunugita N. Prevalence and Characteristics of Chemical Intolerance: A Japanese Population-Based Study. Archives of Environmental & Occupational Health 2014;70:341-53. [DOI: 10.1080/19338244.2014.926855] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
38 Buckley MM, O’Mahony SM, O’Malley D. Convergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome. World J Gastroenterol 2014; 20(27): 8846-8858 [PMID: 25083058 DOI: 10.3748/wjg.v20.i27.8846] [Cited by in F6Publishing: 19] [Reference Citation Analysis]
39 Williams VSL, Nelson LM, Fehnel SE, Macdougall J, Carson RT, Tourkodimitris S, Kurtz C, Baird MJ, Johnston JM. Psychometric validation of symptom severity measures in irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2014;40:298-308. [DOI: 10.1111/apt.12830] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
40 Tuck CJ, Muir JG, Barrett JS, Gibson PR. Fermentable oligosaccharides, disaccharides, monosaccharides and polyols: role in irritable bowel syndrome. Expert Rev Gastroenterol Hepatol. 2014;8:819-834. [PMID: 24830318 DOI: 10.1586/17474124.2014.917956] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 9.0] [Reference Citation Analysis]
41 Lewis JH. Alosetron for severe diarrhea-predominant irritable bowel syndrome: safety and efficacy in perspective. Expert Review of Gastroenterology & Hepatology 2014;4:13-29. [DOI: 10.1586/egh.09.72] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
42 Tang QL, Lin GY, Zhang MQ. Cognitive-behavioral therapy for the management of irritable bowel syndrome. World J Gastroenterol 2013; 19(46): 8605-8610 [PMID: 24379577 DOI: 10.3748/wjg.v19.i46.8605] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
43 Wilson D, Evans M, Weaver E, Shaw AL, Klein GL. Evaluation of serum-derived bovine immunoglobulin protein isolate in subjects with diarrhea-predominant irritable bowel syndrome. Clin Med Insights Gastroenterol 2013;6:49-60. [PMID: 24833942 DOI: 10.4137/CGast.S13200] [Cited by in Crossref: 35] [Cited by in F6Publishing: 42] [Article Influence: 3.9] [Reference Citation Analysis]
44 Usher L, Fox P, Lafarge C, Mitchell K. Factors Associated With Complementary and Alternative Medicine Use in Irritable Bowel Syndrome: A Literature Review. Psychol Community Health 2013;2:346-61. [DOI: 10.5964/pch.v2i3.65] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
45 Farzaneh N, Ghobaklou M, Moghimi-Dehkordi B, Naderi N, Fadai F. Effects of demographic factors, body mass index, alcohol drinking and smoking habits on irritable bowel syndrome: a case control study. Ann Med Health Sci Res. 2013;3:391-396. [PMID: 24116320 DOI: 10.4103/2141-9248.117958] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
46 Nam SY, Ryu KH, Park BJ. Irritable bowel syndrome is associated with gastroesophageal reflux symptom but not erosive esophagitis. J Neurogastroenterol Motil 2013;19:521-31. [PMID: 24199014 DOI: 10.5056/jnm.2013.19.4.521] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
47 Nellesen D, Chawla A, Oh DL, Weissman T, Lavins BJ, Murray CW. Comorbidities in patients with irritable bowel syndrome with constipation or chronic idiopathic constipation: a review of the literature from the past decade. Postgrad Med. 2013;125:40-50. [PMID: 23816770 DOI: 10.3810/pgm.2013.03.2640] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
48 Anastasi JK, Capili B, Chang M. Managing irritable bowel syndrome. Am J Nurs 2013;113:42-52; quiz 54, 53. [PMID: 23764698 DOI: 10.1097/01.NAJ.0000431911.65473.35] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
49 Waehrens R, Ohlsson H, Sundquist J, Sundquist K, Zöller B. Low prevalence of irritable bowel syndrome in primary health care in four Swedish counties. Scand J Prim Health Care 2013;31:132-7. [PMID: 23906034 DOI: 10.3109/02813432.2013.811949] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
50 Sałaga M, Sobczak M, Fichna J. Inhibition of proteases as a novel therapeutic strategy in the treatment of metabolic, inflammatory and functional diseases of the gastrointestinal tract. Drug Discovery Today 2013;18:708-15. [DOI: 10.1016/j.drudis.2013.03.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
51 Sahib AS. Treatment of irritable bowel syndrome using a selected herbal combination of iraqi folk medicines. Journal of Ethnopharmacology 2013;148:1008-12. [DOI: 10.1016/j.jep.2013.05.034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
52 Charbonneau D, Gibb RD, Quigley EM. Fecal excretion of Bifidobacterium infantis 35624 and changes in fecal microbiota after eight weeks of oral supplementation with encapsulated probiotic. Gut Microbes 2013;4:201-11. [PMID: 23549409 DOI: 10.4161/gmic.24196] [Cited by in Crossref: 59] [Cited by in F6Publishing: 45] [Article Influence: 6.6] [Reference Citation Analysis]
53 Sobczak M, Sałaga M, Storr MA, Fichna J. Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives. J Gastroenterol 2014;49:24-45. [PMID: 23397116 DOI: 10.1007/s00535-013-0753-x] [Cited by in Crossref: 106] [Cited by in F6Publishing: 100] [Article Influence: 11.8] [Reference Citation Analysis]
54 Warren JW, Clauw DJ. Functional Somatic Syndromes: Sensitivities and Specificities of Self-Reports of Physician Diagnosis. Psychosomatic Medicine 2012;74:891-5. [DOI: 10.1097/psy.0b013e31827264aa] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
55 Hosseini A, Nikfar S, Abdollahi M. Probiotics use to treat irritable bowel syndrome. Expert Opin Biol Ther. 2012;12:1323-1334. [PMID: 22897430 DOI: 10.1517/14712598.2012.707179] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
56 Quigley EM, Abdel-Hamid H, Barbara G, Bhatia SJ, Boeckxstaens G, De Giorgio R, Delvaux M, Drossman DA, Foxx-Orenstein AE, Guarner F. A global perspective on irritable bowel syndrome: a consensus statement of the World Gastroenterology Organisation Summit Task Force on Irritable Bowel Syndrome. J Clin Gastroenterol. 2012;46:356-366. [PMID: 22499071 DOI: 10.1097/mcg.0b013e318247157c] [Cited by in Crossref: 95] [Cited by in F6Publishing: 92] [Article Influence: 9.5] [Reference Citation Analysis]
57 Koo HL, Sabounchi S, Huang DB, DuPont HL. Rifaximin therapy of irritable bowel syndrome. Clin Med Insights Gastroenterol 2012;5:31-41. [PMID: 24833932 DOI: 10.4137/CGast.S7382] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
58 Olden KW. Targeted therapies for diarrhea-predominant irritable bowel syndrome. Clin Exp Gastroenterol. 2012;5:69-100. [PMID: 22754282 DOI: 10.2147/CEG.S290] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
59 Olden KW. Targeted therapies for diarrhea-predominant irritable bowel syndrome. Clin Exp Gastroenterol. 2012;5:69-100. [PMID: 22754282 DOI: 10.2147/CEG.S29023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
60 Lovell RM, Ford AC. Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis. Am J Gastroenterol. 2012;107:991-1000. [PMID: 22613905 DOI: 10.1038/ajg.2012.131] [Cited by in Crossref: 204] [Cited by in F6Publishing: 217] [Article Influence: 20.4] [Reference Citation Analysis]
61 Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012; 10: 712-721. e4. [PMID: 22426087 DOI: 10.1016/j.cgh.2012.02.029] [Cited by in Crossref: 1156] [Cited by in F6Publishing: 1057] [Article Influence: 115.6] [Reference Citation Analysis]
62 Mazurak N, Seredyuk N, Sauer H, Teufel M, Enck P. Heart rate variability in the irritable bowel syndrome: a review of the literature: Heart rate variability in IBS. Neurogastroenterology & Motility 2012;24:206-16. [DOI: 10.1111/j.1365-2982.2011.01866.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 5.9] [Reference Citation Analysis]
63 Mangel AW, Hicks GA. Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review. Clin Exp Gastroenterol. 2012;5:1-10. [PMID: 22346361 DOI: 10.2147/ceg.s23274] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
64 Harris LA, Heitkemper MM. Practical Considerations for Recognizing and Managing Severe Irritable Bowel Syndrome. Gastroenterology Nursing 2012;35:12-21. [DOI: 10.1097/sga.0b013e31823ff0e8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
65 Barbara G, Cremon C, De Giorgio R, Dothel G, Zecchi L, Bellacosa L, Carini G, Stanghellini V, Corinaldesi R. Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome. Curr Gastroenterol Rep. 2011;13:308-315. [PMID: 21537962 DOI: 10.1007/s11894-011-0195-7] [Cited by in Crossref: 69] [Cited by in F6Publishing: 73] [Article Influence: 6.3] [Reference Citation Analysis]
66 Lucak SL. Optimizing outcomes with alosetron hydrochloride in severe diarrhea-predominant irritable bowel syndrome. Therap Adv Gastroenterol 2010;3:165-72. [PMID: 21180598 DOI: 10.1177/1756283X10362277] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
67 Agarwal N, Spiegel BM. The effect of irritable bowel syndrome on health-related quality of life and health care expenditures. Gastroenterol Clin North Am. 2011;40:11-19. [PMID: 21333898 DOI: 10.1016/j.gtc.2010.12.013] [Cited by in Crossref: 85] [Cited by in F6Publishing: 84] [Article Influence: 7.7] [Reference Citation Analysis]
68 Hammerle CW, Crowe SE. When to reconsider the diagnosis of irritable bowel syndrome. Gastroenterol Clin North Am 2011;40:291-307, vii. [PMID: 21601781 DOI: 10.1016/j.gtc.2011.03.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
69 Abdulmajeed A, Rabab MA, Sliem HA, Hebatallah NE. Pattern of irritable bowel syndrome and its impact on quality of life in primary health care center attendees, Suez governorate, Egypt. Pan Afr Med J 2011;9:5. [PMID: 22145053 DOI: 10.4314/pamj.v9i1.71177] [Cited by in Crossref: 3] [Cited by in F6Publishing: 13] [Article Influence: 0.3] [Reference Citation Analysis]
70 Fuller-thomson E, Sulman J, Brennenstuhl S, Merchant M. Functional Somatic Syndromes and Childhood Physical Abuse in Women: Data From a Representative Community-Based Sample. Journal of Aggression, Maltreatment & Trauma 2011;20:445-69. [DOI: 10.1080/10926771.2011.566035] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
71 Jeffery P, McDonald V, Tippett E, McGuckin M. Ghrelin in gastrointestinal disease. Mol Cell Endocrinol. 2011;340:35-43. [PMID: 21458525 DOI: 10.1016/j.mce.2011.03.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
72 Watier A, Rigaud J, Labat JJ. [Irritable bowel syndrome, levator ani syndrome, proctalgia fugax and chronic pelvic and perineal pain]. Prog Urol 2010;20:995-1002. [PMID: 21056377 DOI: 10.1016/j.purol.2010.08.060] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
73 Chua AS. Prevalence of irritable bowel syndrome in northern India. J Neurogastroenterol Motil 2011;17:6-8. [PMID: 21369486 DOI: 10.5056/jnm.2011.17.1.6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
74 Khan S, Chang L. Diagnosis and management of IBS. Nat Rev Gastroenterol Hepatol. 2010;7:565-581. [PMID: 20890316 DOI: 10.1038/nrgastro.2010.137] [Cited by in Crossref: 78] [Cited by in F6Publishing: 67] [Article Influence: 7.1] [Reference Citation Analysis]
75 Guandalini S, Magazzù G, Chiaro A, La Balestra V, Di Nardo G, Gopalan S, Sibal A, Romano C, Canani RB, Lionetti P. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study. J Pediatr Gastroenterol Nutr. 2010;51:24-30. [PMID: 20453678 DOI: 10.1097/mpg.0b013e3181ca4d95] [Cited by in Crossref: 153] [Cited by in F6Publishing: 140] [Article Influence: 13.9] [Reference Citation Analysis]
76 Chang FY, Lu CL, Chen TS. The current prevalence of irritable bowel syndrome in Asia. J Neurogastroenterol Motil. 2010;16:389-400. [PMID: 21103420 DOI: 10.5056/jnm.2010.16.4.389] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 5.8] [Reference Citation Analysis]
77 Kim ES, Cheon JH, Park JJ, Moon CM, Hong SP, Kim TI, Kim WH. Colonoscopy as an adjunctive method for the diagnosis of irritable bowel syndrome: focus on pain perception. J Gastroenterol Hepatol. 2010;25:1232-1238. [PMID: 20594249 DOI: 10.1111/j.1440-1746.2010.06338.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
78 Burbige EJ. Irritable bowel syndrome: diagnostic approaches in clinical practice. Clin Exp Gastroenterol. 2010;3:127-137. [PMID: 21694856 DOI: 10.2147/ceg.s12596] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
79 Mangel AW, Williams VS. Asimadoline in the treatment of irritable bowel syndrome. Expert Opinion on Investigational Drugs 2010;19:1257-64. [DOI: 10.1517/13543784.2010.515209] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
80 Lin JE, Valentino M, Marszalowicz G, Magee MS, Li P, Snook AE, Stoecker BA, Chang C, Waldman SA. Bacterial heat-stable enterotoxins: translation of pathogenic peptides into novel targeted diagnostics and therapeutics. Toxins (Basel) 2010;2:2028-54. [PMID: 22069671 DOI: 10.3390/toxins2082028] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
81 Adeyemo MA, Spiegel BM, Chang L. Meta-analysis: do irritable bowel syndrome symptoms vary between men and women? Aliment Pharmacol Ther. 2010;32:738-755. [PMID: 20662786 DOI: 10.1111/j.1365-2036.2010.04409.x] [Cited by in Crossref: 100] [Cited by in F6Publishing: 99] [Article Influence: 8.3] [Reference Citation Analysis]
82 Lahmann C, Röhricht F, Sauer N, Noll-Hussong M, Ronel J, Henrich G, von Arnim A, Loew T. Functional relaxation as complementary therapy in irritable bowel syndrome: a randomized, controlled clinical trial. J Altern Complement Med. 2010;16:47-52. [PMID: 20064018 DOI: 10.1089/acm.2009.0084] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
83 Mueller-lissner S, Quigley EMM, Helfrich I, Schaefer E. Drug treatment of chronic-intermittent abdominal cramping and pain: a multi-national survey on usage and attitudes: Abdominal cramping and pain: a multi-national survey. Alimentary Pharmacology & Therapeutics 2010;32:472-7. [DOI: 10.1111/j.1365-2036.2010.04368.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
84 Wright LJ, Schur E, Noonan C, Ahumada S, Buchwald D, Afari N. Chronic pain, overweight, and obesity: findings from a community-based twin registry. J Pain 2010;11:628-35. [PMID: 20338816 DOI: 10.1016/j.jpain.2009.10.004] [Cited by in Crossref: 111] [Cited by in F6Publishing: 114] [Article Influence: 9.3] [Reference Citation Analysis]
85 Suarez K, Mayer C, Ehlert U, Nater UM. Psychological stress and self-reported functional gastrointestinal disorders. J Nerv Ment Dis 2010;198:226-9. [PMID: 20216001 DOI: 10.1097/NMD.0b013e3181d106bc] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
86 Shen L, Kong H, Hou X. Prevalence of irritable bowel syndrome and its relationship with psychological stress status in Chinese university students. J Gastroenterol Hepatol. 2009;24:1885-1890. [PMID: 19780881 DOI: 10.1111/j.1440-1746.2009.05943.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 43] [Article Influence: 2.7] [Reference Citation Analysis]
87 Chey WD, Nojkov B, Rubenstein JH, Dobhan RR, Greenson JK, Cash BD. The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial. Am J Gastroenterol. 2010;105:859-865. [PMID: 20179696 DOI: 10.1038/ajg.2010.55] [Cited by in Crossref: 99] [Cited by in F6Publishing: 100] [Article Influence: 8.3] [Reference Citation Analysis]
88 Lix LM, Yogendran MS, Shaw SY, Targownick LE, Jones J, Bataineh O. Comparing administrative and survey data for ascertaining cases of irritable bowel syndrome: a population-based investigation. BMC Health Serv Res 2010;10:31. [PMID: 20113531 DOI: 10.1186/1472-6963-10-31] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
89 Lee OY. Prevalence and risk factors of irritable bowel syndrome in Asia. J Neurogastroenterol Motil. 2010;16:5-7. [PMID: 20535320 DOI: 10.5056/jnm.2010.16.1.5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
90 Nam SY, Kim BC, Ryu KH, Park BJ. Prevalence and risk factors of irritable bowel syndrome in healthy screenee undergoing colonoscopy and laboratory tests. J Neurogastroenterol Motil. 2010;16:47-51. [PMID: 20535326 DOI: 10.5056/jnm.2010.16.1.47] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
91 Lambrecht RH, Pollard KA, Alshekhlee A, Chelimsky TC, Berti-Mattera LN. The serum of dysautonomia patients enhances proliferation and signaling in Schwann cells. Neurosci Lett 2010;468:130-5. [PMID: 19879922 DOI: 10.1016/j.neulet.2009.10.083] [Reference Citation Analysis]
92 Spiegel BM. The burden of IBS: looking at metrics. Curr Gastroenterol Rep. 2009;11:265-269. [PMID: 19615301 DOI: 10.1007/s11894-009-0039-x] [Cited by in Crossref: 100] [Cited by in F6Publishing: 107] [Article Influence: 7.7] [Reference Citation Analysis]
93 Rey E, Talley NJ. Irritable bowel syndrome: novel views on the epidemiology and potential risk factors. Dig Liver Dis. 2009;41:772-780. [PMID: 19665952 DOI: 10.1016/j.dld.2009.07.005] [Cited by in Crossref: 75] [Cited by in F6Publishing: 68] [Article Influence: 5.8] [Reference Citation Analysis]
94 McNally MA, Locke GR, Zinsmeister AR, Schleck CD, Peterson J, Talley NJ. Biliary events and an increased risk of new onset irritable bowel syndrome: a population-based cohort study. Aliment Pharmacol Ther 2008;28:334-43. [PMID: 19086237 DOI: 10.1111/j.1365-2036.2008.03715.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
95 Hun L. Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS. Postgrad Med. 2009;121:119-124. [PMID: 19332970 DOI: 10.3810/pgm.2009.03.1984] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 4.7] [Reference Citation Analysis]
96 Lembo AJ, Zaman M, Krueger RF, Tomenson BM, Creed FH. Psychiatric disorder, irritable bowel syndrome, and extra-intestinal symptoms in a population-based sample of twins. Am J Gastroenterol 2009;104:686-94. [PMID: 19223882 DOI: 10.1038/ajg.2009.23] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
97 Tang S, Lee S, Hynan LS, Yan J, Riley FC, Armstrong L, Rodriguez-frias E, Xu L, Pruna E, Lara LF, Sreenarasimhaiah J, Choi KW, Rockey DC. Endoscopic Hemostasis in Nonvariceal Upper Gastrointestinal Bleeding: Comparison of Physician Practice in the East and the West. Dig Dis Sci 2009;54:2418-26. [DOI: 10.1007/s10620-008-0689-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
98 Brandt LJ, Chey WD, Foxx-orenstein AE, Quigley EM, Schiller LR, Schoenfeld PS, Spiegel BM, Talley NJ, Moayyedi P. An Evidence-Based Systematic Review on the Management of Irritable Bowel Syndrome: . American Journal of Gastroenterology 2009;104:S8-S35. [DOI: 10.14309/00000434-200901001-00002] [Cited by in Crossref: 54] [Cited by in F6Publishing: 29] [Article Influence: 4.2] [Reference Citation Analysis]
99 Dai N, Cong Y, Yuan H. Prevalence of irritable bowel syndrome among undergraduates in Southeast China. Digestive and Liver Disease 2008;40:418-24. [DOI: 10.1016/j.dld.2008.01.019] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
100 Halpert A, Dalton CB, Palsson O, Morris C, Hu Y, Bangdiwala S, Hankins J, Norton N, Drossman DA. Patient educational media preferences for information about irritable bowel syndrome (IBS). Dig Dis Sci. 2008;53:3184-3190. [PMID: 18463981 DOI: 10.1007/s10620-008-0280-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
101 Kovács Z, Kovács F. Depressive and anxiety symptoms, dysfunctional attitudes and social aspects in irritable bowel syndrome and inflammatory bowel disease. Int J Psychiatry Med. 2007;37:245-255. [PMID: 18314852 DOI: 10.2190/pm.37.3.a] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 4.0] [Reference Citation Analysis]
102 Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L, Hungin P, Jones R, Kumar D, Rubin G, Trudgill N, Whorwell P; Clinical Services Committee of The British Society of Gastroenterology. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 2007;56:1770-98. [PMID: 17488783 DOI: 10.1136/gut.2007.119446] [Cited by in Crossref: 543] [Cited by in F6Publishing: 483] [Article Influence: 36.2] [Reference Citation Analysis]
103 Jankovic J, Tsui J, Bergeron C. Prevalence of cervical dystonia and spasmodic torticollis in the United States general population. Parkinsonism & Related Disorders 2007;13:411-6. [DOI: 10.1016/j.parkreldis.2007.02.005] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 4.4] [Reference Citation Analysis]
104 Smith JL, Bayles D. Postinfectious irritable bowel syndrome: a long-term consequence of bacterial gastroenteritis. J Food Prot 2007;70:1762-9. [PMID: 17685356 DOI: 10.4315/0362-028x-70.7.1762] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
105 Park KS, Ahn SH, Hwang JS, Cho KB, Chung WJ, Jang BK, Kang YN, Kwon JH, Kim YH. A survey about irritable bowel syndrome in South Korea: prevalence and observable organic abnormalities in IBS patients. Dig Dis Sci. 2008;53:704-711. [PMID: 17717743 DOI: 10.1007/s10620-007-9930-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
106 Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L, Hungin P, Jones R, Kumar D, Rubin G, Trudgill N. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut. 2007;56:1770-1798. [PMID: 17488783 DOI: 10.1136/gut.2007.119446corr1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
107 Miller D, Bennett L, Hollis K, Tennis P, Cook S, Andrews E. A patient follow-up survey programme for alosetron: assessing compliance to and effectiveness of the risk management programme. Aliment Pharmacol Ther 2006;24:869-78. [PMID: 16918892 DOI: 10.1111/j.1365-2036.2006.03031.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
108 Williams RE, Black CL, Kim HY, Andrews EB, Mangel AW, Buda JJ, Cook SF. Determinants of healthcare-seeking behaviour among subjects with irritable bowel syndrome. Aliment Pharmacol Ther. 2006;23:1667-1675. [PMID: 16696818 DOI: 10.1111/j.1365-2036.2006.02928.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
109 Williams RE, Black CL, Kim HY, Andrews EB, Mangel AW, Buda JJ, Cook SF. Stability of irritable bowel syndrome using a Rome II-based classification. Aliment Pharmacol Ther. 2006;23:197-205. [PMID: 16393298 DOI: 10.1111/j.1365-2036.2006.02723.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]